The policy "Transparency in Clinical Research" focusses on laying initiatives to improve clinical research for health care systems, patients, and caregivers.
The issue concerns the publications of reports that are biased. Over the years, the cases studied and results generated have never been published. This has been a concern to health care personnel (Health Affairs, 2016). Ideally, lack of reliable information and transparency has created extreme implication in the health care sector. The essence of the policy is to address the clinical research done. Selective publication of clinical research by the stakeholders has been causing barriers to other useful clinical research.
The stakeholders are from the health sector and outside the area of health. It forms a broad consultation sector. They include health workers, patient and health service users, government, business and the private sectors, community groups and civil society organization. According to FDA (Food and Drug Administration), the data released were not made available to the public concerning the trials per drug. It is considered unethical to fail to publish useful literature concerning medical research (Health care policies and institutions, 2010, p. 121). Governments have also established a universal health care that takes the burden of health expenses of private businesses or individuals by pooling resources.
The current state of the policy has shown efforts to renew the policy and ensure transparency is achieved. The policy has taken a twist in approaching the literature published. Underlying data, wide scopes, and registration of the research has been done. Trial data access has been improved by “European Medicines Agency” (EMA) (Health Affairs, 2016).
The future reforms will typically attempt to broaden the population coverage of the policy through either, public sector, insurance programs or private sectors. They also focus on improving the quality of health care hence giving more good care to citizens.
References
Health care policies and institutions. (2010). Health Care Systems, 95-126. doi:10.1787/9789264094901-6-en
Health Affairs. (2016). Transparency in Clinical Research. Health Policy Briefs. Retrieved from https://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=150
